REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lukas Biomedical Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lukas Biomedical Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Lukas Biomedical Inc. focuses on the research and development of immune cell therapy technology. The company was founded in 2013 and is headquartered in New Taipei City, Taiwan.

Headquarters
No.14-16, Zxongxiao Rd., Banqiao Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Lukas Biomedical Inc. report to view the information.

Website: http://www.lukas-biomedical.com

Basic Information
Total Employees:
Purchase the Lukas Biomedical Inc. report to view the information.
Outstanding Shares:
Purchase the Lukas Biomedical Inc. report to view the information.
Financial Auditors:
Purchase the Lukas Biomedical Inc. report to view the information.
Incorporation Date:
December 26, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.77%
Purchase this report to view the information.
14.09%
Purchase this report to view the information.
8.05%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Grand Zone International Biomedical INC.
Company Performance
Financial values in the chart are available after Lukas Biomedical Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.74%▼
Total operating revenue
-14.61%▼
Operating profit (EBIT)
-224.76%▼
EBITDA
N/A
Net Profit (Loss) for the Period
-176.54%▼
Total assets
24.25%▲
Total equity
21.34%▲
Operating Profit Margin (ROS)
-29.34%▼
Net Profit Margin
-28.87%▼
Return on Equity (ROE)
-6.01%▼
Debt to Equity Ratio
24.79%▲
Quick Ratio
0.9%▲
Cash Ratio
1.09%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
BiOptic Inc.
 
Panbiotic Laboratories Co.,Ltd.
Bioray Biotech Co., Ltd.
 
Joben Bio-Medical Co., Ltd. (Pingtung County) (乔本生医 (屏东县))
G&E Herbal Biotechnology Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo